We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$106B
AUM Growth
+$3.62B
Cap. Flow
-$1.47B
Cap. Flow %
-1.39%
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$281M
2
AMZN icon
Amazon
AMZN
+$228M
3
TWX
Time Warner Inc
TWX
+$219M
4
LLY icon
Eli Lilly
LLY
+$212M
5
RTX icon
RTX Corp
RTX
+$208M

Sector Composition

Rank Sector Weight
1 Financials 16.44%
2 Healthcare 15.11%
3 Industrials 11.28%
4 Energy 10.95%
5 Technology 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHI icon
1176
National Health Investors
NHI
$3.9B
$1.84M ﹤0.01%
29,435
+5,352
+22% +$330K
SCI icon
1177
Service Corp International
SCI
$11.4B
$1.84M ﹤0.01%
88,633
-625,200
-88% -$12.2M
BWLD
1178
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$1.82M ﹤0.01%
10,974
-1,653
-13% -$243K
CW icon
1179
Curtiss-Wright
CW
$27.7B
$1.81M ﹤0.01%
27,646
-4,944
-15% -$324K
ENTA icon
1180
Enanta Pharmaceuticals
ENTA
$372M
$1.81M ﹤0.01%
42,004
+40,051
+2,051% +$1.53M
AL
1181
DELISTED
Air Lease Corp
AL
$1.8M ﹤0.01%
46,699
+33,238
+247% +$1.27M
WES
1182
DELISTED
Western Gas Partners Lp
WES
$1.8M ﹤0.01%
23,514
STE icon
1183
Steris
STE
$20.9B
$1.79M ﹤0.01%
33,521
-5,426
-14% -$279K
GTLS
1184
DELISTED
Chart Industries
GTLS
$1.78M ﹤0.01%
21,558
+1,340
+7% +$101K
MS icon
1185
PUT
Morgan Stanley
MS
$337B
$1.78M ﹤0.01%
+55,000
New +$1.7M
RGLS
1186
DELISTED
Regulus Therapeutics
RGLS
$1.78M ﹤0.01%
1,842
+3
+0.2% +$2.57K
TBHC
1187
DELISTED
The Brand House Collective
TBHC
$1.77M ﹤0.01%
95,228
+13,821
+17% +$243K
CLC
1188
DELISTED
Clarcor
CLC
$1.76M ﹤0.01%
28,489
-4,257
-13% -$246K
CRR
1189
DELISTED
Carbo Ceramics Inc.
CRR
$1.74M ﹤0.01%
11,319
-1,855
-14% -$256K
ANN
1190
DELISTED
ANN INC
ANN
$1.74M ﹤0.01%
42,377
-4,429
-9% -$177K
QURE icon
1191
uniQure
QURE
$2.68B
$1.74M ﹤0.01%
+128,100
New +$1.39M
HNGR
1192
DELISTED
Hanger Inc.
HNGR
$1.74M ﹤0.01%
55,288
-3,813
-6% -$123K
MMYT icon
1193
MakeMyTrip
MMYT
$4.67B
$1.73M ﹤0.01%
49,300
-16,300
-25% -$414K
PRXL
1194
DELISTED
Parexel International Corp
PRXL
$1.73M ﹤0.01%
32,728
-20,511
-39% -$1.03M
PRAA icon
1195
PRA Group
PRAA
$648M
$1.72M ﹤0.01%
28,875
-4,902
-15% -$280K
IRWD icon
1196
Ironwood Pharmaceuticals
IRWD
$611M
$1.71M ﹤0.01%
133,476
-12,699
-9% -$138K
AVB icon
1197
AvalonBay Communities
AVB
$27.1B
$1.71M ﹤0.01%
12,002
+6,346
+112% +$877K
DBI icon
1198
Designer Brands
DBI
$277M
$1.7M ﹤0.01%
60,965
+50,073
+460% +$1.58M
SSNC icon
1199
SS&C Technologies
SSNC
$17.8B
$1.7M ﹤0.01%
76,954
-2,526
-3% -$52.3K
WST icon
1200
West Pharmaceutical
WST
$23.1B
$1.7M ﹤0.01%
40,258
-5,813
-13% -$249K

Similar funds

BlackRock Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

  • BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
  • BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
  • BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
  • BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
  • BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
  • BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.